Vanguard Group Inc. Sells 4,211 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Vanguard Group Inc. cut its position in ICU Medical, Inc. (NASDAQ:ICUIFree Report) by 0.2% during the third quarter, Holdings Channel.com reports. The institutional investor owned 2,125,626 shares of the medical instruments supplier’s stock after selling 4,211 shares during the quarter. Vanguard Group Inc. owned 0.09% of ICU Medical worth $252,971,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the company. Covestor Ltd raised its stake in shares of ICU Medical by 86.4% in the first quarter. Covestor Ltd now owns 123 shares of the medical instruments supplier’s stock valued at $27,000 after acquiring an additional 57 shares during the last quarter. Pinebridge Investments L.P. acquired a new position in ICU Medical in the second quarter worth $39,000. Private Trust Co. NA boosted its stake in ICU Medical by 1,428.6% in the third quarter. Private Trust Co. NA now owns 321 shares of the medical instruments supplier’s stock worth $38,000 after purchasing an additional 300 shares in the last quarter. Point72 Hong Kong Ltd bought a new stake in shares of ICU Medical during the first quarter worth $94,000. Finally, Group One Trading L.P. increased its stake in shares of ICU Medical by 54.6% in the first quarter. Group One Trading L.P. now owns 566 shares of the medical instruments supplier’s stock valued at $126,000 after buying an additional 200 shares in the last quarter. 96.10% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the stock. CL King initiated coverage on shares of ICU Medical in a report on Thursday, December 14th. They set a “buy” rating and a $110.00 price objective on the stock. KeyCorp increased their price target on shares of ICU Medical from $134.00 to $136.00 and gave the company an “overweight” rating in a research note on Wednesday, February 28th. One equities research analyst has rated the stock with a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $123.00.

Check Out Our Latest Analysis on ICU Medical

ICU Medical Trading Up 4.3 %

Shares of NASDAQ ICUI opened at $107.32 on Friday. The company’s 50 day simple moving average is $100.67 and its 200 day simple moving average is $100.78. The company has a debt-to-equity ratio of 0.74, a current ratio of 2.53 and a quick ratio of 1.06. ICU Medical, Inc. has a fifty-two week low of $78.28 and a fifty-two week high of $212.43. The firm has a market capitalization of $2.59 billion, a P/E ratio of -87.25 and a beta of 0.70.

ICU Medical (NASDAQ:ICUIGet Free Report) last issued its earnings results on Tuesday, February 27th. The medical instruments supplier reported $1.24 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.85 by $0.39. The firm had revenue of $587.86 million for the quarter, compared to analysts’ expectations of $564.77 million. ICU Medical had a positive return on equity of 6.35% and a negative net margin of 1.31%. On average, analysts predict that ICU Medical, Inc. will post 3.52 EPS for the current year.

Insider Activity at ICU Medical

In other ICU Medical news, COO Christian B. Voigtlander sold 13,603 shares of the stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $107.19, for a total value of $1,458,105.57. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other ICU Medical news, VP Daniel Woolson sold 791 shares of ICU Medical stock in a transaction dated Friday, March 15th. The stock was sold at an average price of $98.27, for a total value of $77,731.57. Following the sale, the vice president now owns 13,980 shares of the company’s stock, valued at approximately $1,373,814.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Christian B. Voigtlander sold 13,603 shares of the company’s stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $107.19, for a total value of $1,458,105.57. The disclosure for this sale can be found here. Insiders sold a total of 24,262 shares of company stock worth $2,545,532 in the last quarter. Corporate insiders own 7.50% of the company’s stock.

ICU Medical Profile

(Free Report)

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.

Read More

Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Inc. (NASDAQ:ICUIFree Report).

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.